...
首页> 外文期刊>Ophthalmic epidemiology >Epidemiology of Hyphema-Related Emergency Department Visits in The United States Between 2006 and 2015
【24h】

Epidemiology of Hyphema-Related Emergency Department Visits in The United States Between 2006 and 2015

机译:2006年至2015年Quphema相关急诊部门访问的流行病学

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To describe epidemiological trends, risk factors, and hospital-associated charges for patients presenting with hyphema to emergency departments (EDs) throughout the United States (U.S.). Methods: Cross-sectional analysis of all hyphema-related ED cases in the U.S. Nationwide Emergency Department Sample (NEDS) between 2006 and 2015 to determine population-based incidence rates, patient demographics, visit characteristics and associated charges. Results: Between 2006 and 2015, there were a total of 16,222 cases with hyphema as primary visit diagnosis (0.52 ED visits per 100,000 population). The mean (SD) age at presentation was 37.4 (24.8) years, and males accounted for 66.2% of these cases. Trauma (n = 4,994, 30.8%) was the most frequently identified etiology, with sports-related injuries as important contributor. On multivariate analysis, traumatic hyphema was more likely for patients aged 5-14 years (Odds ratio [OR] = 1.88 [95% Confidence interval [CI]: 1.04-3.40, p = 0.04]) than 0-4 years, males (OR = 1.33 [95% CI: 1.09-1.62, p = 0.01]), in May through September (OR = 1.66-1.93 [95% CI: 1.08-3.05, p = 0.005-0.03]),and for those in the highest income quartile (OR = 1.42 [95% CI: 1.10-1.83, p = 0.01]). Visits were less likely for patients aged >= 55 years (OR = 0.49 [95% CI: 0.25-0.994, p = 0.03]) than 0-4 years. During the study period, hyphema accounted for $21 million in ED associated and $9 million in inpatient charges. Conclusion: ED visits with hyphema as primary diagnosis occur at an annual rate of 0.52 per 100,000 population. Young males are particularly at risk and there has been an increase in the number of sports-related injuries which may represent a modifiable cause. Hyphema management costs $3 million in hospital-related charges annually.
机译:目的:描述在整个美国(美国)的Qualphema患者患者的流行病学趋势,危险因素和医院相关费用。方法:2006年至2015年美国全国急救署样本(NEDS)对所有Quphema相关案件的横截面分析,以确定基于人口的分析,患者的发病率,患者人口统计学,访问特征和相关指控。结果:2006年至2015年间,共有16,222例Quphema作为主要访问诊断(每10万人次数0.52次)。介绍的平均值(SD)年龄为37.4(24.8)岁,男性占这些案件的66.2%。创伤(n = 4,994,30.8%)是最常见的鉴定病因,与体育有关的伤害是重要的贡献者。在多变量分析中,5-14岁的患者更有可能更有可能(差距[或] = 1.88 [95%置信区间[CI]:1.04-3.40,P = 0.04]),比0-4岁,男性(或= 1.33 [95%CI:1.09-1.62,P = 0.01]),5月至9月(或= 1.66-1.93 [95%CI:1.08-3.05,P = 0.005-0.03]),以及那些最高的收入四分位数(或= 1.42 [95%CI:1.10-1.83,P = 0.01])。对于55岁(或= 0.49 [95%CI:0.25-0.994,P = 0.03])的患者,患者可能不太可能比0-4岁。在研究期间,Quphema占ED的2100万美元,关联费用为900万美元。结论:催化剂作为初级诊断的审查,每10万人的年速度为0.52。年轻的男性特别有风险,体育伤害数量可能增加,可能代表可修改的原因。 QUPHEMA管理每年在医院相关的费用中费用为300万美元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号